Showing results (121-130 of 1,827) with videos related to

Sort By:
Pageof 183
ESMO Open|October 26, 2024
Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinomaM H Hong, S Park, T Vo, et al.
ESMO Open|October 26, 2024
Tislelizumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced squamous non-small-cell lung cancer: final analysis of the randomized, phase III RATIONALE-307 trialJ Wang, S Lu, X Yu, et al.
ESMO Open|March 5, 2025
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysisR Cohen, M Raeisi, B Chibaudel, et al.
ESMO Open|August 7, 2024
Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective studyL Guidi, C Valenza, E Battaiotto, et al.
ESMO Open|August 3, 2024
Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international studyE Chatziioannou, L M Serna Higuita, S Kreft, et al.
ESMO Open|August 31, 2024
Total pain, opioids, and immune checkpoint inhibitors in the survival of patients with cancerC I Ripamonti, C Chelazzi
ESMO Open|August 30, 2024
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumorsT A Yap, A D Choudhury, E Hamilton, et al.
ESMO Open|August 30, 2024
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)E J Kang, Y Yang, S Lee, et al.
ESMO Open|August 9, 2024
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trialF Poggio, E Blondeaux, M Tagliamento, et al.
ESMO Open|August 13, 2024
Bioimpedance-derived body composition parameters predict mortality and dose-limiting toxicity: the multicenter ONCO-BIVA studyE Cereda, A Casirati, C Klersy, et al.
Pageof 183